The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...

While colorectal cancer polyps often have no symptoms—especially in the early stages—there are some warning signs to be on ...

Coral reefs contribute more than $1.2 billion through reef-related tourism to the state of Hawai‘i economy, and are worth an ...

Months after announcing his battle with kidney cancer, former Southern Baptist Convention President Steven Gaines, says he s ...

Hydra oligactis, a freshwater creature related to jellyfish and sea anemones that is considered 'immortal' in many ways, ...

On detection of diminutive polyps (defined as measuring ≤ 5 mm), further assessment with hWLE followed by NBI was performed. These assessments were digitally recorded (high-definition video ...

Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...

New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids AstraZeneca’s Fasenra (benralizumab) ...

Urology Week 2024, which closes out Urology Awareness Month, is a good time to highlight the innovations in this space.

REGN gets FDA nod for Dupixent for a broader population for the indication of chronic rhinosinusitis with nasal polyps.

Commonly used fecal immunochemical tests vary in their performance, which has implications for the benefits and ...